The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q3 2017 call → NOWe need answer YES or NO based on transcript. Need determine if management conveys recently finished expensive/heavy phase of major undertaking and now collecting phase with results still reflecting paying phase. Transcript: SB Financial Group Q3 2017. They discuss strategic initiatives, growth, mortgage, SBA, wealth management, expansion into markets, new offices, hiring. Need see if any major undertaking heavy phase completed and now collecting. They mention "Our relentless focus on our five key strategic initiatives continues to drive our performance." They talk about market expansions, new office in Findlay, Columbus, new loan production office in Gahanna, hiring SBA officers, equipment leasing. But do they say heavy phase done? They say "We have detailed plans to continue to drive each to a higher level with more well defined service level agreements in 2018." Not really. They mention "Our three year presence in one of Ohio’s best markets has provided meaningful organic balance sheet growth." Findlay office expansion. "We have plans that solidify our presence in this market and wealth management and private banking to further capitalize on our business banking successes." Not heavy phase done. They mention "we recently purchased and remodeled a new loan production office in the upscale eastern suburb of Gahanna. Initially we will house our mortgage professionals and our SBA officer but intend to launch an interactive [Inaudible] machine strategy..." This is recent purchase/remodel, but not described as completed heavy phase with collecting beginning? They say "to not only utilize our Dublin retail staff more effectively, but to potentially capture additional products and services with our over 4,000 single service mortgage households." That's future potential. They mention "We recently hired a seasoned executive in the Northeast Indiana region and expect to leverage his expertise into a new business line for State Bank and also add more diversity to our commercial lending product line up." That's hiring, not completed. They mention "Our strategic goal of $1 billion is within our reach this year" for servicing portfolio. Not heavy phase. They mention "we’re on track to deliver over $1.2 million in loan sale gains for the year, representing total SBA production of over $17 million." That's ongoing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.